1. Home
  2. Labeler Index
  3. Astrazeneca Pharmaceuticals Lp
  4. 0310-6512
  5. NDC Package Code: 0310-6512-85 Byetta

NDC Package 0310-6512-85 Byetta

Exenatide Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0310-6512-85
Package Description:
1 CARTRIDGE in 1 CARTON / 1.2 mL in 1 CARTRIDGE
Product Code:
0310-6512
Proprietary Name:
Byetta
Non-Proprietary Name:
Exenatide
Substance Name:
Exenatide
Usage Information:
Exenatide is used with a proper diet and exercise program to control high blood sugar. It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Exenatide is a diabetes drug that is similar to a natural hormone in your body (incretin). It works by increasing insulin release (especially after a meal) and decreasing the amount of sugar your liver makes. It also slows down food digestion in your stomach, decreases the amount of sugar absorbed from food, and may help decrease your appetite.
11-Digit NDC Billing Format:
00310651285
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Astrazeneca Pharmaceuticals Lp
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
EXENATIDE 250 ug/mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
NDA021773
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
12-10-2014
End Marketing Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
0310-6512-011 CARTRIDGE in 1 CARTON / 1.2 mL in 1 CARTRIDGE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0310-6512-85?

The NDC Packaged Code 0310-6512-85 is assigned to a package of 1 cartridge in 1 carton / 1.2 ml in 1 cartridge of Byetta, a human prescription drug labeled by Astrazeneca Pharmaceuticals Lp. The product's dosage form is injection and is administered via subcutaneous form.

Is NDC 0310-6512 included in the NDC Directory?

Yes, Byetta with product code 0310-6512 is active and included in the NDC Directory. The product was first marketed by Astrazeneca Pharmaceuticals Lp on December 10, 2014.

What is the 11-digit format for NDC 0310-6512-85?

The 11-digit format is 00310651285. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20310-6512-855-4-200310-6512-85